Acid-sensing ion channels (ASICs) are activated by acidic pH and may play a significant role in the development of hyperalgesia. Earlier studies show ASIC3 is important for induction of hyperalgesia after muscle insult using ASIC3À/À mice. ASIC3À/À mice lack ASIC3 throughout the body, and the distribution and composition of ASICs could be different from wild-type mice. We therefore tested whether knockdown of ASIC3 in primary afferents innervating muscle of adult wild-type mice prevented development of hyperalgesia to muscle inflammation. We cloned and characterized artificial miRNAs (miR-ASIC3) directed against mouse ASIC3 (mASIC3) to downregulate ASIC3 expression in vitro and in vivo. In CHO-K1 cells transfected with mASIC3 cDNA in culture, the miR-ASIC3 constructs inhibited protein expression of mASIC3 and acidic pH-evoked currents and had no effect on protein expression or acidic pH-evoked currents of ASIC1a. When miR-ASIC3 was used in vivo, delivered into the muscle of mice using a herpes simplex viral vector, both muscle and paw mechanical hyperalgesia were reduced after carrageenan-induced muscle inflammation. ASIC3 mRNA in DRG and protein levels in muscle were decreased in vivo by miR-ASIC3. In CHO-K1 cells co-transfected with ASIC1a and ASIC3, miR-ASIC3 reduced the amplitude of acidic pH-evoked currents, suggesting an overall inhibition in the surface expression of heteromeric ASIC3-containing channels. Our results show, for the first time, that reducing ASIC3 in vivo in primary afferent fibers innervating muscle prevents the development of inflammatory hyperalgesia in wild-type mice, and thus, may have applications in the treatment of musculoskeletal pain in humans.
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Introduction
Acid-sensing ion channels (ASICs) are activated by protons and belong to the epithelial sodium channel/degenerin (ENaC/ DEG) family of amiloride-sensitive proteins [8, 27, 50, 62] . Four genes within mammalian genomes encode several splice variants including ASIC1a, ASIC1b, ASIC1b2, ASIC2a, ASIC2b, ASIC3, and ASIC4, which are thought to combine as heteromers to form functional ion channels [5, 14, 23] . Each of the ASICs display unique biophysical properties, such as different pH sensitivities, current kinetics, ion selectivities, and pharmacological sensitivities [1, 4, 16, 17, 28] .
ASICs are expressed on neurons including nociceptors, and are ideally located to be activated by the acidic pH that occurs after inflammation or ischemia [20, 21, 32, 37, 40, 59, 60] . Previous studies of ASICs and inflammatory hyperalgesia have yielded conflicting results, often depending on the location or the inflammatory animal model used. In models of paw inflammation, ASIC3 null or knockdown mice show no change or enhanced hyperalgesia when compared with wild-type controls [6, 31, 40, 51] . Models of cutaneous inflammation measure hyperalgesia at the site of injury, ie, primary hyperalgesia, but not at sites distant from the injury, ie, secondary hyperalgesia. In contrast, models of musculoskeletal pain have examined the roles of ASICs in both primary and secondary hyperalgesia. Prior work shows that ASIC1 and ASIC3 play differential roles in the development of both primary and secondary hyperalgesia after deep-tissue injury. Specifically, after muscle inflammation, ASIC3À/À mice do not develop secondary hyperalgesia, but still develop primary hyperalgesia, whereas ASIC1À/À mice do not develop primary hyperalgesia, but still develop secondary hyperalgesia [20, 49, 58, 65] .
Although the ASIC knockout mice are invaluable tools for examining the role of ASICs and pain, they lack specific ASIC subunits 
